Olfactory bulb involvement in neurodegenerative diseases

Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O’Brien PC, Plevak MF, Kurland LT (1998) Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 51:1672–1677 Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Comella C, Colcher A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Rezak M, Novak KE, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Clark LN, Marder K (2011) Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology 76:319–326 Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson’s disease. J Neurol 255(Suppl 5):18–32 Ansoleaga B, Garcia-Esparcia P, Llorens F, Moreno J, Aso E, Ferrer I (2013) Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 248C:369–382 Arnold SE, Han LY, Moberg PJ, Turetsky BI, Gur RE, Trojanowski JQ, Hahn CG (2001) Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch Gen Psychiatry 58:829–835 Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, Trojanowski JQ (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 67:462–469 Attems J, Lintner F, Jellinger KA (2005) Olfactory involvement in aging and Alzheimer’s disease: an autopsy study. J Alzheimers Dis 7:149–157 (discussion 173–180) Attems J, Jellinger KA (2006) Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 25:265–271 Attems J, Alpar A, Spence L, McParland S, Heikenwalder M, Uhlen M, Tanila H, Hokfelt TG, Harkany T (2012) Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation. Proc Natl Acad Sci USA 109:6259–6264 Attems J, Jellinger K (2013) Neuropathological correlates of cerebral multimorbidity. Curr Alzheimer Res 10:569–577 Averback P (1983) Two new lesions in Alzheimer’s disease. Lancet 2:1203 Baba T, Takeda A, Kikuchi A, Nishio Y, Hosokai Y, Hirayama K, Hasegawa T, Sugeno N, Suzuki K, Mori E, Takahashi S, Fukuda H, Itoyama Y (2011) Association of olfactory dysfunction and brain. Metabolism in Parkinson’s disease. Mov Disord 26:621–628 Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S, Hasegawa T, Sugeno N, Konno M, Suzuki K, Takahashi S, Fukuda H, Aoki M, Itoyama Y, Mori E, Takeda A (2012) Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson’s disease: a 3 year longitudinal study. Brain 135:161–169 Babizhayev MA, Deyev AI, Yegorov YE (2011) Olfactory dysfunction and cognitive impairment in age-related neurodegeneration: prevalence related to patient selection, diagnostic criteria and therapeutic treatment of aged clients receiving clinical neurology and community-based care. Curr Clin Pharmacol 6:236–259 Bahar-Fuchs A, Chetelat G, Villemagne VL, Moss S, Pike K, Masters CL, Rowe C, Savage G (2010) Olfactory deficits and amyloid-beta burden in Alzheimer’s disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis 22:1081–1087 Bahar-Fuchs A, Moss S, Rowe C, Savage G (2010) Olfactory performance in AD, aMCI, and healthy ageing: a unirhinal approach. Chem Senses 35:855–862 Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S (2012) Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 323:16–24 Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J (2007) Olfaction and neurodegeneration in HD. NeuroReport 18:73–76 Beach TG, White CL 3rd, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174 Belluscio L, Gold GH, Nemes A, Axel R (1998) Mice deficient in G(olf) are anosmic. Neuron 20:69–81 Benarroch EE (2010) Olfactory system: functional organization and involvement in neurodegenerative disease. Neurology 75:1104–1109 Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson’s disease. J Neurol Sci 310:21–24 Bhatnagar KP, Kennedy RC, Baron G, Greenberg RA (1987) Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat Rec 218:73–87 Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Mov Disord 23:1984–1990 Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, Moore RY (2007) Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol 254:84–90 Bohnen NI, Gedela S, Herath P, Constantine GM, Moore RY (2008) Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neurosci Lett 447:12–16 Bohnen NI, Muller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133:1747–1754 Bohnen NI, Muller ML (2013) In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s disease. J Neural Transm 120:571–576 Bovi T, Antonini A, Ottaviani S, Antonioli A, Cecchini MP, Di Francesco V, Bassetto MA, Zamboni M, Fiaschi A, Moretto G, Sbarbati A, Osculati F, Tinazzi M (2010) The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. J Neurol 257:1882–1889 Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211 Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134 Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404 Braga-Neto P, Felicio AC, Hoexter MQ, Pedroso JL, Dutra LA, Alessi H, Minett T, Santos-Galduroz RF, da Rocha AJ, Garcia LA, Bertolucci PH, Bressan RA, Barsottini OG (2012) Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study. Parkinsonism Relat Disord 18:854–858 Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C (2012) Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-tesla magnetic resonance imaging. Mov Disord 27:1019–1025 Brunet LJ, Gold GH, Ngai J (1996) General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel. Neuron 17:681–693 Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC (1992) Olfactory function in essential tremor. Neurology 42:1631–1632 Cai Y, Xue ZQ, Zhang XM, Li MB, Wang H, Luo XG, Cai H, Yan XX (2012) An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation. Neuroscience 215:160–173 Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW (2012) Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3:1009 Cassano T, Romano A, Macheda T, Colangeli R, Cimmino CS, Petrella A, LaFerla FM, Cuomo V, Gaetani S (2011) Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 224:408–412 Cheng N, Cai H, Belluscio L (2011) In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function. J Neurosci 31:13699–13704 Cheng N, Bai L, Steuer E, Belluscio L (2013) Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer’s disease model. J Neurosci 33:12208–12217 Chiba Y, Fujishiro H, Iseki E, Ota K, Kasanuki K, Hirayasu Y, Satoa K (2012) Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer’s disease. Dement Geriatr Cogn Disord 33:273–281 Chiu WH, Carlsson T, Depboylu C, Hoglinger GU, Oertel WH, Ries V (2013) Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson’s disease. Neuropharmacology 79C:212–221 Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J (2003) Early olfactory involvement in Alzheimer’s disease. Can J Neurol Sci 30:20–25 Conti MZ, Vicini-Chilovi B, Riva M, Zanetti M, Liberini P, Padovani A, Rozzini L (2013) Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer’s disease. Arch Clin Neuropsychol 28:391–399 Corona C, Porcario C, Martucci F, Iulini B, Manea B, Gallo M, Palmitessa C, Maurella C, Mazza M, Pezzolato M, Acutis P, Casalone C (2009) Olfactory system involvement in natural scrapie disease. J Virol 83:3657–3667 Crino PB, Martin JA, Hill WD, Greenberg B, Lee VM, Trojanowski JQ (1995) Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer’s disease, Parkinson’s disease, and Down syndrome. Ann Otol Rhinol Laryngol 104:655–661 Cross DJ, Anzai Y, Petrie EC, Martin N, Richards TL, Maravilla KR, Peskind ER, Minoshima S (2013) Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. J Nucl Med 54:1278–1284 Davies DC, Brooks JW, Lewis DA (1993) Axonal loss from the olfactory tracts in Alzheimer’s disease. Neurobiol Aging 14:353–357 Demarquay G, Ryvlin P, Royet JP (2007) Olfaction and neurological diseases: a review of the literature. Rev Neurol (Paris) 163:155–167 Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 157:1399–1405 Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, Andrews H, Brown TR, DeCarli C, Mayeux R (2010) Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 31:1593–1600 Dibattista M, Massimino ML, Maurya DK, Menini A, Bertoli A, Sorgato MC (2011) The cellular prion protein is expressed in olfactory sensory neurons of adult mice but does not affect the early events of the olfactory transduction pathway. Chem Senses 36:791–797 Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706 Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244 Doty RL, Perl DP, Steele JC, Chen KM, Pierce JD Jr, Reyes P, Kurland LT (1991) Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer’s and idiopathic Parkinson’s disease. Neurology 41(Suppl. 2):77–80 Doty RL, Singh A, Tetrud J, Langston JW (1992) Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32:97–100 Doty RL (2007) Olfaction in Parkinson’s disease. Parkinsonism Relat Disord 13(Suppl 3):S225–S228 Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7–15 Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46:527–552 Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8:329–339 Duda JE, Shah U, Arnold SE, Lee VM, Trojanowski JQ (1999) The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 160:515–522 Duda JE (2010) Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289:49–54 Dudova I, Hrdlicka M (2013) Olfactory functions are not associated with autism severity in autism spectrum disorders. Neuropsychiatr Dis Treat 9:1847–1851 Dziewulska D, Doi H, Fasano A, Erro R, Fatehi F, Fekete R, Gatto EM, Pablos EG, Lehn A, Miyajima H, Piperno A, Pellechia MT, Wu YR, Yoshida K, Zarruk JG, Jingli S, Schrag A, McNeill A (2013) Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation. Acta Neuropathol 126:151–153 Evidente VG, Esteban RP, Hernandez JL, Natividad FF, Advincula J, Gwinn-Hardy K, Hardy J, Singleton A (2004) Smell testing is abnormal in ‘lubag’ or X-linked dystonia-parkinsonism: a pilot study. Parkinsonism Relat Disord 10:407–410 Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 70:386–390 Fernandez-Ruiz J, Diaz R, Hall-Haro C, Vergara P, Fiorentini A, Nunez L, Drucker-Colin R, Ochoa A, Yescas P, Rasmussen A, Alonso ME (2003) Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. NeuroReport 14:1339–1341 Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Laruffa M, Guidubaldi A, Paludetti G, Albanese A, Barone P, Dallapiccola B, Valente EM, Bentivoglio AR (2009) Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord 24:2350–2357 Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF (2008) Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 28:247–256 Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S (2010) Functional representation of olfactory impairment in early Alzheimer’s disease. J Alzheimers Dis 22:581–591 Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies. Acta Neuropathol 116:17–24 Funabe S, Takao M, Saito Y, Hatsuta H, Sugiyama M, Ito S, Kanemaru K, Sawabe M, Arai T, Mochizuki H, Hattori N, Murayama S (2013) Neuropathologic analysis of Lewy-related alpha-synucleinopathy in olfactory mucosa. Neuropathology 33:47–58 Furtado S, Wszolek ZK (2013) Olfactory dysfunction. In: Pfeiffer RF, Bodis-Wollner I (eds) Parkinson’s disease and nonmotor dysfunction. Humana Press Inc., Totowa, pp 245–253 Fusetti M, Fioretti AB, Silvagni F, Simaskou M, Sucapane P, Necozione S, Eibenstein A (2010) Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment. J Otolaryngol Head Neck Surg 39:175–181 Gallarda BW, Lledo PM (2012) Adult neurogenesis in the olfactory system and neurodegenerative disease. Curr Mol Med 12:1253–1260 Garcia-Esparcia P, Schluter A, Carmona M, Moreno J, Ansoleaga B, Torrejon-Escribano B, Gustincich S, Pujol A, Ferrer I (2013) Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol 72:524–539 Garland EM, Raj SR, Peltier AC, Robertson D, Biaggioni I (2011) A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology 76:456–460 Getchell ML, Shah DS, Buch SK, Davis DG, Getchell TV (2003) 3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer’s disease: implications for impaired odor sensitivity. Neurobiol Aging 24:663–673 Glass PG, Lees AJ, Mathias C, Mason L, Best C, Williams DR, Katzenschlager R, Silveira-Moriyama L (2012) Olfaction in pathologically proven patients with multiple system atrophy. Mov Disord 27:327–328 Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353–1357 Goldstein DS, Sewell L (2009) Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord 15:516–520 Goldstein DS, Sewell L, Holmes C (2010) Association of anosmia with autonomic failure in Parkinson disease. Neurology 74:245–251 Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB (1999) Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 53:1480–1487 Haehner A, Hummel T, Reichmann H (2013) A clinical approach towards smell loss in Parkinson’s disease. J Parkinsons Dis. doi:10.3233/JPD-130278 Haehner A, Hummel T, Wolz M, Klingelhofer L, Fauser M, Storch A, Reichmann H (2013) Effects of rasagiline on olfactory function in patients with Parkinson’s disease. Mov Disord 28:2023–2027 Hawkes C (2003) Olfaction in neurodegenerative disorder. Mov Disord 18:364–372 Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 62:436–446 Hawkes CH, Doty RL (2009) The neurology of olfaction. Cambridge University Press, Cambridge Hensiek AE, Bhatia KP, Hawkes CH (2000) Olfactory function in drug-induced parkinsonism. J Neurol 247:P303 Herting B, Bietenbeck S, Scholz K, Hahner A, Hummel T, Reichmann H (2008) Olfactory dysfunction in Parkinson’s disease: its role as a new cardinal sign in early and differential diagnosis. Nervenarzt 79:175–184 Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson’s disease. J Neurol 255:367–370 Hirai T, Kojima S, Shimada A, Umemura T, Sakai M, Itakura C (1996) Age-related changes in the olfactory system of dogs. Neuropathol Appl Neurobiol 22:531–539 Hock C, Golombowski S, Muller-Spahn F, Peschel O, Riederer A, Probst A, Mandelkow E, Unger J (1998) Histological markers in nasal mucosa of patients with Alzheimer’s disease. Eur Neurol 40:31–36 Hovakimyan M, Meyer A, Lukas J, Luo J, Gudziol V, Hummel T, Rolfs A, Wree A, Witt M (2013) Olfactory deficits in Niemann-Pick Type C1 (NPC1) disease. PLoS ONE 8:e82216 Hower RE, Rick JH, Balderston CC, Weintraub D, Siderowf AD, Stern M, Moberg PJ, Duda JE (2008) Olfactory dysfunction and Parkinson’s disease progression. Neurology 70:A397–A398 Hoyles K, Sharma JC (2013) Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach. J Neurol 260:2951–2958 Hu J, Wang X, Liu D, Wang Q, Zhu LQ (2012) Olfactory deficits induce neurofilament hyperphosphorylation. Neurosci Lett 506:180–183 Hubbard PS, Esiri MM, Reading M, McShane R, Nagy Z (2007) Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat 211:117–124 Huisman E, Uylings HB, Hoogland PV (2004) A 100 % increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov Disord 19:687–692 Huisman E, Uylings HB, Hoogland PV (2008) Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson’s disease patients. Mov Disord 23:1407–1413 Hussain A, Luong M, Pooley A, Nathan BP (2013) Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture. J Biomed Sci 20:49 Ibarretxe-Bilbao N, Junque C, Marti MJ, Valldeoriola F, Vendrell P, Bargallo N, Zarei M, Tolosa E (2010) Olfactory impairment in Parkinson’s disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov Disord 25:1888–1894 Iijima M, Osawa M, Momose M, Kobayakawa T, Saito S, Iwata M, Uchiyama S (2010) Cardiac sympathetic degeneration correlates with olfactory function in Parkinson’s disease. Mov Disord 25:1143–1149 Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomena F, Vilas D, Llado A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453 Jafek BW, Murrow B, Michaels R, Restrepo D, Linschoten M (2002) Biopsies of human olfactory epithelium. Chem Senses 27:623–628 Jellinger KA (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:215–216; author reply 217–218 Kaakkola S, Palo J, Malmberg H, Sulkava R, Virtanen I (1994) Neurofilament profile in olfactory mucosa of patients with a clinical diagnosis of Alzheimer’s disease. Virchows Arch 424:315–319 Kang P, Kloke J, Jain S (2012) Olfactory dysfunction and parasympathetic dysautonomia in Parkinson’s disease. Clin Auton Res 22:161–166 Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17:417–423 Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1749–1752 Kertelge L, Bruggemann N, Schmidt A, Tadic V, Wisse C, Dankert S, Drude L, van der Vegt J, Siebner H, Pawlack H, Pramstaller PP, Behrens MI, Ramirez A, Reichel D, Buhmann C, Hagenah J, Klein C, Lohmann K, Kasten M (2010) Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Mov Disord 25:2665–2669 Khan NL, Katzenschlager R, Watt H, Bhatia KP, Wood NW, Quinn N, Lees AJ (2004) Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 62:1224–1226 Kim YH, Lussier S, Rane A, Choi SW, Andersen JK (2011) Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction. Neuroscience 172:379–386 Kishikawa M, Iseki M, Nishimura M, Sekine I, Fujii H (1990) A histopathological study on senile changes in the human olfactory bulb. Acta Pathol Jpn 40:255–260 Kovacs I, Torok I, Zombori J, Kasa P (1998) Cholinergic structures and neuropathologic alterations in the olfactory bulb of Alzheimer’s disease brain samples. Brain Res 789:167–170 Kovacs T, Cairns NJ, Lantos PL (1999) beta-Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease. Neuropathol Appl Neurobiol 25:481–491 Kovacs T, Cairns NJ, Lantos PL (2001) Olfactory centres in Alzheimer’s disease: olfactory bulb is involved in early Braak’s stages. NeuroReport 12:285–288 Kovacs T (2013) The olfactory system in Alzheimer’s disease: pathology, pathophysiology and pathway for therapy. Translat Neurosci 4:34–45 Kranick SM, Duda JE (2008) Olfactory dysfunction in Parkinson’s disease. Neurosignals 16:35–40 Krismer F, Wenning GK, Li Y, Poewe W, Stefanova N (2013) Intact olfaction in a mouse model of multiple system atrophy. PLoS ONE 8:e64625 Kruger S, Haehner A, Thiem C, Hummel T (2008) Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. J Neurol 255:1574–1579 Kulkarni-Narla A, Getchell TV, Schmitt FA, Getchell ML (1996) Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: increased immunoreactivity in Alzheimer’s disease. Exp Neurol 140:115–125 Lang CJ, Schwandner K, Hecht M (2011) Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotroph Lateral Scler 12:368–371 Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598–605 Larsson M, Farde L, Hummel T, Witt M, Lindroth NE, Backman L (2009) Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen. Neuroscience 161:422–426 Lazic SE, Goodman AO, Grote HE, Blakemore C, Morton AJ, Hannan AJ, van Dellen A, Barker RA (2007) Olfactory abnormalities in Huntington’s disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients. Brain Res 1151:219–226 Le Pichon CE, Firestein S (2008) Expression and localization of the prion protein PrP(C) in the olfactory system of the mouse. J Comp Neurol 508:487–499 Lee JH, Goedert M, Hill WD, Lee VM, Trojanowski JQ (1993) Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol 121:93–105 Lee YH, Simmons MM, Hawkins SA, Spencer YI, Webb P, Stack MJ, Wells GA (2009) Detection of pathologic prion protein in the olfactory bulb of natural and experimental bovine spongiform encephalopathy affected cattle in Great Britain. Vet Pathol 46:59–62 Lehrner J, Pusswald G, Gleiss A, Auff E, Dal-Bianco P (2009) Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment. Clin Neuropsychol 23:818–830 Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL (2012) Profound olfactory dysfunction in myasthenia gravis. PLoS ONE 7:e45544 Lerner A, Bagic A (2008) Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 23:1076–1084 Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491 Li W, Howard JD, Gottfried JA (2010) Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer’s disease. Brain 133:2714–2726 Lischka FW, Gomez G, Yee KK, Dankulich-Nagrudny L, Lo L, Haskins ME, Rawson NE (2008) Altered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI. J Comp Neurol 511:360–372 Liu Q, Li A, Gong L, Zhang L, Wu N, Xu F (2013) Decreased coherence between the two olfactory bulbs in Alzheimer’s disease model mice. Neurosci Lett 545:81–85 Loopuijt LD, Sebens JB (1990) Loss of dopamine receptors in the olfactory bulb of patients with Alzheimer’s disease. Brain Res 529:239–244 Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA (2007) Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45:1823–1831 Macknin JB, Higuchi M, Lee VM, Trojanowski JQ, Doty RL (2004) Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein. Brain Res 1000:174–178 Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Pfeiffer RF, Wszolek ZK (1997) Olfactory dysfunction in familial parkinsonism. Neurology 49:1262–1267 Marxreiter F, Nuber S, Kandasamy M, Klucken J, Aigner R, Burgmayer R, Couillard-Despres S, Riess O, Winkler J, Winner B (2009) Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Eur J Neurosci 29:879–890 Masaoka Y, Yoshimura N, Inoue M, Kawamura M, Homma I (2007) Impairment of odor recognition in Parkinson’s disease caused by weak activations of the orbitofrontal cortex. Neurosci Lett 412:45–50 May VE, Nuber S, Marxreiter F, Riess O, Winner B, Winkler J (2012) Impaired olfactory bulb neurogenesis depends on the presence of human wild-type alpha-synuclein. Neuroscience 222:343–355 McCurdy RD, Feron F, Perry C, Chant DC, McLean D, Matigian N, Hayward NK, McGrath JJ, Mackay-Sim A (2006) Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res 82:163–173 McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872 McLaughlin NC, Westervelt HJ (2008) Odor identification deficits in frontotemporal dementia: a preliminary study. Arch Clin Neuropsychol 23:119–123 Meusel T, Westermann B, Fuhr P, Hummel T, Welge-Lussen A (2010) The course of olfactory deficits in patients with Parkinson’s disease—a study based on psychophysical and electrophysiological measures. Neurosci Lett 486:166–170 Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer’s disease. A primer for practicing pathologists. Arch Pathol Lab Med 117:132–144 Miyamoto T (2012) Olfactory dysfunction in Parkinson disease and REM sleep behavior disorder. Brain Nerve 64:356–363 Moessnang C, Frank G, Bogdahn U, Winkler J, Greenlee MW, Klucken J (2011) Altered activation patterns within the olfactory network in Parkinson’s disease. Cereb Cortex 21:1246–1253 Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11 Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N (2013) MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol Dis 55:1–10 Morley JF, Duda JE (2010) Olfaction as a biomarker in Parkinson’s disease. Biomark Med 4:661–670 Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson’s disease. Mov Disord 26:2051–2057 Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, Ranvaud R, Liu J, McFarland K, Ashizawa T, Lees AJ, Silveira-Moriyama L (2012) Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry 83:970–974 Mueller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T (2006) Extrapyramidal symptoms in Wilson’s disease are associated with olfactory dysfunction. Mov Disord 21:1311–1316 Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9:521–524 Mundinano IC, Caballero MC, Ordonez C, Hernandez M, DiCaudo C, Marcilla I, Erro ME, Tunon MT, Luquin MR (2011) Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol 122:61–74 Mundinano IC, Hernandez M, Dicaudo C, Ordonez C, Marcilla I, Tunon MT, Luquin MR (2013) Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta Neuropathol 126:411–425 Nguyen AD, Shenton ME, Levitt JJ (2010) Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements. Harv Rev Psychiatry 18:279–292 Nores JM, Biacabe B, Bonfils P (2000) Olfactory disorders in Alzheimer’s disease and in Parkinson’s disease. Review of the literature. Ann Med Interne (Paris) 151:97–106 Nuber S, Petrasch-Parwez E, Arias-Carrion O, Koch L, Kohl Z, Schneider J, Calaminus C, Dermietzel R, Samarina A, Boy J, Nguyen HP, Teismann P, Velavan TP, Kahle PJ, von Horsten S, Fendt M, Kruger R, Riess O (2011) Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson’s disease stages. Neurobiol Dis 44:192–204 Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E (2014) Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD. Acta Neuropathol in print. doi:10.1007/s00401-00014-01255-00405 Ohm TG, Braak H (1987) Olfactory bulb changes in Alzheimer’s disease. Acta Neuropathol 73:365–369 Oka H, Toyoda C, Yogo M, Mochio S (2010) Olfactory dysfunction and cardiovascular dysautonomia in Parkinson’s disease. J Neurol 257:969–976 Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R (2005) Anosmia is very common in the Lewy body variant of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:1342–1347 Olofsson JK, Nordin S, Wiens S, Hedner M, Nilsson LG, Larsson M (2010) Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol Aging 31:567–577 Ozdener MH, Rawson NE (2004) Olfactory dysfunction in neurodegenerative diseases. Eur J General Med 1:1–11 Pardini M, Huey ED, Cavanagh AL, Grafman J (2009) Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol 66:92–96 Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML (2012) Olfactory deficits and cognitive dysfunction in Parkinson’s disease. Neurodegener Dis 10:179–182 Patel RM, Pinto JM (2014) Olfaction: anatomy, physiology, and disease. Clin Anat 27:54–60 Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2008) Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79:874–880 Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10:283–287 Perry G, Castellani RJ, Smith MA, Harris PL, Kubat Z, Ghanbari K, Jones PK, Cordone G, Tabaton M, Wolozin B, Ghanbari H (2003) Oxidative damage in the olfactory system in Alzheimer’s disease. Acta Neuropathol 106:552–556 Petit GH, Berkovich E, Hickery M, Kallunki P, Fog K, Fitzer-Attas C, Brundin P (2013) Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson’s disease. PLoS ONE 8:e60691 Petrovitch H, Duda JE, Abbott RD, Nelson J, Noorigian JV, Tanner CM, Masaki K, White LR, Uyehara-Lock J, Ross W (2008) Lewy pathology in the olfactory bulb is associated with decreased neuron density in the substantia nigra (abstr.). Mov Disord 23(suppl 1):S29 Poddighe S, Bhat KM, Setzu MD, Solla P, Angioy AM, Marotta R, Ruffilli R, Marrosu F, Liscia A (2013) Impaired sense of smell in a Drosophila Parkinson’s model. PLoS ONE 8:e73156 Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181 Ponsen MM, Stoffers D, Wolters E, Booij J, Berendse HW (2010) Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson’s disease. J Neurol Neurosurg Psychiatry 81:396–399 Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811–818 Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson’s disease. Exp Neurol 202:391–403 Rahayel S, Frasnelli J, Joubert S (2012) The effect of Alzheimer’s disease and Parkinson’s disease on olfaction: a meta-analysis. Behav Brain Res 231:60–74 Rajapaksha TW, Eimer WA, Bozza TC, Vassar R (2011) The Alzheimer’s beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener 6:88 Rawson NE, Gomez G, Cowart B, Restrepo D (1998) The use of olfactory receptor neurons (ORNs) from biopsies to study changes in aging and neurodegenerative diseases. Ann NY Acad Sci 855:701–707 Rey NL, Jardanhazi-Kurutz D, Terwel D, Kummer MP, Jourdan F, Didier A, Heneka MT (2012) Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. Neurobiol Aging 33:426e1–426e11 Rey NL, Petit GH, Bousset L, Melki R, Brundin P (2013) Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol 126:555–573 Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson’s disease. J Neurol 258:1254–1260 Ronnett GV, Leopold D, Cai X, Hoffbuhr KC, Moses L, Hoffman EP, Naidu S (2003) Olfactory biopsies demonstrate a defect in neuronal development in Rett’s syndrome. Ann Neurol 54:206–218 Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21:2062–2067 Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173 Ruan Y, Zheng XY, Zhang HL, Zhu W, Zhu J (2012) Olfactory dysfunctions in neurodegenerative disorders. J Neurosci Res 90:1693–1700 Ruiz-Martinez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodriguez F, Bergareche A, Moreno F, Lopez de Munain A, Marti Masso JF (2011) Olfactory deficits and cardiac 123I-MIBG in Parkinson’s disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 26:2026–2031 Sajjadian A, Doty RL, Gutnick DN, Chirurgi RJ, Sivak M, Perl D (1994) Olfactory dysfunction in amytrophic lateral sclerosis. Neurodegeneration 3:153–157 Sattler R, Ayukawa Y, Coddington L, Sawa A, Block D, Chipkin R, Rothstein JD (2011) Human nasal olfactory epithelium as a dynamic marker for CNS therapy development. Exp Neurol 232:203–211 Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, Severt L, Raymond D, Ozelius LJ, Lipton RB, Bressman SB (2011) Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 77:319–324 Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129:538–542 Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K (2013) Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease. Brain 136:3028–3037 Schneider F, Habel U, Reske M, Toni I, Falkai P, Shah NJ (2007) Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res 155:103–112 Schofield PW, Ebrahimi H, Jones AL, Bateman GA, Murray SR (2012) An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease. BMC Neurol 12:24 Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemaru K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S (2008) Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072–1083 Serby M, Larson P, Kalkstein D (1991) The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 148:357–360 Shah M, Muhammed N, Findley LJ, Hawkes CH (2008) Olfactory tests in the diagnosis of essential tremor. Parkinsonism Relat Disord 14:563–568 Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB (2007) Risk factors for Parkinson’s disease and impaired olfaction in relatives of patients with Parkinson’s disease. Mov Disord 22:2249–2255 Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K (2012) Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 27:406–412 Sierra M, Sanchez-Juan P, Martinez-Rodriguez MI, Gonzalez-Aramburu I, Garcia-Gorostiaga I, Quirce MR, Palacio E, Carril JM, Berciano J, Combarros O, Infante J (2013) Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease. Neurology 80:621–626 Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ (2008) Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 71:1021–1026 Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, Poewe W, Maier H, Lees AJ, Revesz T (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453:77–80 Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ (2009) Hyposmia in pure autonomic failure. Neurology 72:1677–1681 Silveira-Moriyama L, Schwingenschuh P, O’Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ (2009) Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 80:744–748 Silveira-Moriyama L, Munhoz RP, de Carvalho M, Raskin S, Rogaeva E, de Aguiar CAP, Bressan RA, Felicio AC, Barsottini OG, Andrade LA, Chien HF, Bonifati V, Barbosa ER, Teive HA, Lees AJ (2010) Olfactory heterogeneity in LRRK2 related Parkinsonism. Mov Disord 25:2879–2883 Sliger M, Lander T, Murphy C (2004) Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. J Alzheimers Dis 6:397–402 (discussion 443–399) Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A (2010) Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson’s disease. Mov Disord 25:2099–2104 Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137 Struble RG, Clark HB (1992) Olfactory bulb lesions in Alzheimer’s disease. Neurobiol Aging 13:469–473 Sun GH, Raji CA, Maceachern MP, Burke JF (2012) Olfactory identification testing as a predictor of the development of Alzheimer’s dementia: a systematic review. Laryngoscope 122:1455–1462 Tabaton M, Monaco S, Cordone MP, Colucci M, Giaccone G, Tagliavini F, Zanusso G (2004) Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann Neurol 55:294–296 Takeda A (2013) Severe olfactory dysfunction is a predictor of dementia with Parkinson’s disease. Rinsho Shinkeigaku 53:91–97 Takeda T, Uchihara T, Kawamura S, Ohashi T (2014) Olfactory dysfunction related to TDP-43 pathology in amyotrophic lateral sclerosis. Clin Neuropathol 33:65–67 Talamo BR, Rudel R, Kosik KS, Lee VM, Neff S, Adelman L, Kauer JS (1989) Pathological changes in olfactory neurons in patients with Alzheimer’s disease. Nature 337:736–739 Talamo BR, Feng WH, Perez-Cruet M, Adelman L, Kosik K, Lee MY, Cork LC, Kauer JS (1991) Pathologic changes in olfactory neurons in Alzheimer’s disease. Ann NY Acad Sci 640:1–7 ter Laak HJ, Renkawek K, van Workum FP (1994) The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer Dis Assoc Disord 8:38–48 Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800 Thomann PA, Dos Santos V, Seidl U, Toro P, Essig M, Schroder J (2009) MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 17:213–221 Thompson MD, Knee K, Golden CJ (1998) Olfaction in persons with Alzheimer’s disease. Neuropsychol Rev 8:11–23 Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16:41–46 Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O’Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1–120): implications for Lewy body disorders. J Neurosci 26:3942–3950 Trojanowski JQ, Newman PD, Hill WD, Lee VM (1991) Human olfactory epithelium in normal aging, Alzheimer’s disease, and other neurodegenerative disorders. J Comp Neurol 310:365–376 Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW (2003) Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol 29:503–510 Turetsky BI, Hahn CG, Borgmann-Winter K, Moberg PJ (2009) Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr Bull 35:1117–1131 Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Argandona-Palacios L, Garcia-Munozguren S, Martinez-Marcos A (2010) alpha-Synucleinopathy in the human olfactory system in Parkinson’s disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol 119:723–735 Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Mohedano-Moriano A, Fradejas N, Calvo S, Argandona-Palacios L, Garcia-Munozguren S, Martinez-Marcos A (2010) Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson’s disease: cell types involved. Mov Disord 25:1701–1707 Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2012) alpha-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections. Brain Struct Funct 217:447–458 Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2013) alpha-Synuclein in the olfactory system in Parkinson’s disease: role of neural connections on spreading pathology. Brain Struct Funct in print. doi:10.1007/s00429-00013-00651-00422 Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697 van de Berg W, Zweekhorst S, Voorn P, Groenewegen H, Hoogland P, Rozemuller AM (2007) Pattern of a-synuclein and phosphorylated tau pathology in the olfactory bulb, brainstem and limbic regions in aged individuals (abstr.). Parkinsonism Relat Disord 13:S122 Velazquez-Perez L, Fernandez-Ruiz J, Diaz R, Gonzalez RP, Ochoa NC, Cruz GS, Mederos LE, Gongora EM, Hudson R, Drucker-Colin R (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 253:1165–1169 Verbaan D, Boesveldt S, van Rooden SM, Visser M, Marinus J, Macedo MG, Fang Y, Heutink P, Berendse HW, van Hilten JJ (2008) Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 71:1877–1882 Wang J, Eslinger PJ, Doty RL, Zimmerman EK, Grunfeld R, Sun X, Meadowcroft MD, Connor JR, Price JL, Smith MB, Yang QX (2010) Olfactory deficit detected by fMRI in early Alzheimer’s disease. Brain Res 1357:184–194 Wang J, You H, Liu JF, Ni DF, Zhang ZX, Guan J (2011) Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am J Neuroradiol 32:677–681 Wattendorf E, Welge-Lussen A, Fiedler K, Bilecen D, Wolfensberger M, Fuhr P, Hummel T, Westermann B (2009) Olfactory impairment predicts brain atrophy in Parkinson’s disease. J Neurosci 29:15410–15413 Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91:247–250 Wesson DW, Levy E, Nixon RA, Wilson DA (2010) Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer’s disease mouse model. J Neurosci 30:505–514 Westermann B, Wattendorf E, Schwerdtfeger U, Husner A, Fuhr P, Gratzl O, Hummel T, Bilecen D, Welge-Lussen A (2008) Functional imaging of the cerebral olfactory system in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 79:19–24 Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R (2009) Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 80:667–670 Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett SA (2009) Olfactory impairment in presymptomatic Alzheimer’s disease. In: Finger TE (ed) International Symposium on Olfaction and Taste. New York Academy of Sciences New York, pp 730–735 Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA (2011) Lewy bodies and olfactory dysfunction in old age. Chem Senses 36:367–373 Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197:113–121 Winner B, Rockenstein E, Lie DC, Aigner R, Mante M, Bogdahn U, Couillard-Despres S, Masliah E, Winkler J (2008) Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis. Neurobiol Aging 29:913–925 Witoonpanich P, Cash DM, Shakespeare TJ, Yong KX, Nicholas JM, Omar R, Crutch SJ, Rossor MN, Warren JD (2013) Olfactory impairment in posterior cortical atrophy. J Neurol Neurosurg Psychiatry 84:588–590 Witt M, Bormann K, Reichmann H, Gudziol V, Hähner A, Barth K, Hummel T (2008) Olfactory epithelium in patients with Parkinson’s disease (Abstr.). 6th Int Congr Mental Dysfunctions & Other Non-Motor Features in Parkinson’s Disease and Related Disorders, Dresden, Oct 16-19, 2008 Abstracts on CD-ROM, Kenes International, Geneva:Abstr.# 117 Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A, Hahner A, Reichmann H, Hummel T (2009) Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov Disord 24:906–914 Wong KK, Muller ML, Kuwabara H, Studenski SA, Bohnen NI (2010) Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci Lett 484:163–167 Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, Li K, Chan P (2011) Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease. Eur Neurol 66:98–105 Yamagishi M, Ishizuka Y (1994) Abnormal tau protein expression in biopsied human olfactory mucosa. Nippon Jibiinkoka Gakkai Kaiho 97:466–472 Yamagishi M, Ishizuka Y, Seki K (1994) Pathology of olfactory mucosa in patients with Alzheimer’s disease. Ann Otol Rhinol Laryngol 103:421–427 Yamagishi M, Takami S, Getchell TV (1996) Ontogenetic expression of spot 35 protein (calbindin-D28 k) in human olfactory receptor neurons and its decrease in Alzheimer’s disease patients. Ann Otol Rhinol Laryngol 105:132–139 Yamagishi M, Getchell ML, Takami S, Getchell TV (1998) Increased density of olfactory receptor neurons immunoreactive for apolipoprotein E in patients with Alzheimer’s disease. Ann Otol Rhinol Laryngol 107:421–426 Yamamoto T (1991) Involvement of the olfactory system in learning and memory: a close correlation between the olfactory deficit and the course of Alzheimer’s disease? Yakubutsu Seishin Kodo 11:223–235 Zanusso G, Ferrari S, Cardone F, Zampieri P, Gelati M, Fiorini M, Farinazzo A, Gardiman M, Cavallaro T, Bentivoglio M, Righetti PG, Pocchiari M, Rizzuto N, Monaco S (2003) Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 348:711–719